Venatorx Pharmaceuticals, Inc. Funding: $46M Raised
Venatorx Pharmaceuticals, Inc. is based in Malvern. It has raised $46M in total funding. Latest round: Series B.
Venatorx Pharmaceuticals, Inc. funding overview
Venatorx Pharmaceuticals, Inc. is based in Malvern. Venatorx Pharmaceuticals, Inc. has raised $46M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in July 2017. The round record for Venatorx Pharmaceuticals, Inc. runs through 2017; nothing later has been disclosed. Investors on record include Versant Ventures, Abingworth, Foresite Capital. 3 distinct backers are named across the disclosed rounds.
Venatorx Pharmaceuticals, Inc. at a glance
Total raised
$46M
Latest round
Series B
Latest round date
July 2017
Headquarters
Malvern
Notable investors
Versant Ventures, Abingworth, Foresite Capital
Frequently asked about Venatorx Pharmaceuticals, Inc. funding
How much has Venatorx Pharmaceuticals, Inc. raised?
Venatorx Pharmaceuticals, Inc. has raised $46M in total disclosed funding across the rounds on record.
Who has invested in Venatorx Pharmaceuticals, Inc.?
Versant Ventures, Abingworth, Foresite Capital are named among the investors backing Venatorx Pharmaceuticals, Inc..
What was the latest Venatorx Pharmaceuticals, Inc. funding round?
The most recent disclosed round is a Series B, announced in July 2017.
Where is Venatorx Pharmaceuticals, Inc. based?
Venatorx Pharmaceuticals, Inc. is based in Malvern.
When did Venatorx Pharmaceuticals, Inc. last raise?
The last disclosed Venatorx Pharmaceuticals, Inc. round closed in July 2017 at Series B.
We update the Venatorx Pharmaceuticals, Inc. record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Malvern and their backers are listed below.
Companies related to Venatorx Pharmaceuticals, Inc. (20)
